IPMNs are thought to progress from benign neoplasms to invasive cancers through DNA damage/mutation. The damaged DNA loses protective factors and undergoes malignant degeneration leading to uncontrolled growth and convalescence. KRAS and/or GNAS mutations have been identified in IPMNs.